Resource Center
Resource Center
The report provides market intelligence on hepatitis C diagnostics and drugs in low- and middle-income countries and covers preliminary insights into the hepatitis B market.
Read moreNew approaches to ending vertical transmission of hepatitis B overlap with HIV reduction strategies.
Read moreCHAI supported an analysis, published in Clinical Infectious Diseases, identifying readily available, generic HepC treatments that have been successfully used as second-line therapy for patients in Egypt, Georgia, and Myanmar.
Read moreRevisit our most popular blog posts from 2020, as we highlight the challenges and successes of our work over the last year.
Read moreA new article published in BMJ Global Health details results of five years of CHAI support to governments as they initiate and scale up hepatitis C programs across seven low- and middle-income countries.
Read moreWe are pleased to release our annual report. This year's theme is 'transformational change'.
Read moreThis World Hepatitis Day, even as we pivot to respond to COVID-19, we cannot neglect the ongoing needs of people with chronic illnesses, such as viral hepatitis.
Read moreThe report provides an overview of the supplier landscape for WHO recommended drugs and diagnostics, outlines supply and pricing trends, highlights global benchmark prices, and suggests ways in which low- and middle-income countries can access testing and treatment at more affordable prices.
Read moreCHAI is proud of the progress that we have made over the past year to address health issues in low- and middle-income countries. We have not made that progress alone. We work closely with governments, other organizations and community groups, as well as the private sector, to save lives and reduce the burden of...
Read moreThe theme for the 2018 Annual Report is ‘Our Approach in Action’. There are examples in each program section of a time that CHAI’s approach was successfully applied to support our partners toward our mission.
Read more